Trinity Bio ADR (TRIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 90,435 | 97,035 | 99,140 | 99,611 | 100,195 |
| Cost of Goods | 52,315 | 55,586 | 57,250 | 56,127 | 53,683 |
| Gross Profit | 38,120 | 41,449 | 41,890 | 43,484 | 46,512 |
| Operating Expenses | 62,547 | 62,262 | 79,808 | 83,459 | 33,689 |
| Operating Income | -24,112 | -20,227 | -37,668 | -39,848 | 13,506 |
| Interest Expense | 6,582 | 5,080 | 5,405 | 5,439 | 4,054 |
| Other Income | 697 | 2,124 | 3,198 | 3,147 | 13,491 |
| Pre-tax Income | -29,997 | -23,183 | -39,875 | -42,140 | 22,943 |
| Income Tax | -1,006 | -525 | -1,214 | -3,557 | 756 |
| Net Income Continuous | -28,991 | -22,658 | -38,661 | -38,583 | 22,187 |
| Net Income Discontinuous | 77 | 568 | -1,609 | -62,042 | -391 |
| Net Income | $-28,914 | $-22,090 | $-40,270 | $-100,625 | $21,796 |
| EPS Basic Total Ops | -34.50 | -26.50 | -46.50 | -109.50 | 23.50 |
| EPS Basic Continuous Ops | -34.59 | -27.10 | -44.70 | -42.00 | 23.95 |
| EPS Basic Discontinuous Ops | 0.09 | 0.68 | -1.86 | -67.54 | -0.42 |
| EPS Diluted Total Ops | -34.50 | -26.50 | -46.50 | -109.50 | 11.50 |
| EPS Diluted Continuous Ops | -34.59 | -21.89 | -35.96 | -34.09 | 20.24 |
| EPS Diluted Discontinuous Ops | 0.09 | 0.55 | -1.50 | -54.81 | -0.36 |
| EPS Diluted Before Non-Recurring Items | -0.75 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-19,218 | $-16,106 | $-32,469 | $-33,716 | $19,148 |